FDC
Quarterly Results Analysis [Sep2025]
FDC Quarterly Results
| Consolidated | Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 Audited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 Audited |
Dec2023 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹473 Cr | ₹648 Cr | ₹492 Cr | ₹464 Cr | ₹514 Cr | ₹638 Cr | ₹462 Cr | ₹458 Cr |
| Expenses | ₹439 Cr | ₹508 Cr | ₹438 Cr | ₹417 Cr | ₹444 Cr | ₹492 Cr | ₹406 Cr | ₹374 Cr |
| Operating Income | ₹34 Cr | ₹140 Cr | ₹54 Cr | ₹47 Cr | ₹70 Cr | ₹147 Cr | ₹56 Cr | ₹84 Cr |
| Other Income | ₹21 Cr | ₹36 Cr | ₹16 Cr | ₹19 Cr | ₹35 Cr | ₹28 Cr | ₹20 Cr | ₹25 Cr |
| Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Depreciation | ₹15 Cr | ₹15 Cr | ₹16 Cr | ₹13 Cr | ₹14 Cr | ₹11 Cr | ₹10 Cr | ₹10 Cr |
| Profit Before Tax | ₹38 Cr | ₹160 Cr | ₹53 Cr | ₹51 Cr | ₹90 Cr | ₹163 Cr | ₹65 Cr | ₹98 Cr |
| Profit After Tax | ₹28 Cr | ₹121 Cr | ₹39 Cr | ₹37 Cr | ₹72 Cr | ₹119 Cr | ₹46 Cr | ₹79 Cr |
| EPS | ₹1.74 | ₹7.45 | ₹2.38 | ₹2.28 | ₹4.42 | ₹7.31 | ₹2.84 | ₹4.87 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| FDC | 1.4% | -4.8% | -17.3% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.2% | 5.3% | 0.9% |
| DIVIS LABORATORIES | -0.7% | -2.1% | 12.4% |
| CIPLA | -0.2% | -6.7% | 1.8% |
| TORRENT PHARMACEUTICALS | -3.2% | 4.1% | 20.2% |
| DR REDDYS LABORATORIES | 0.2% | -2.7% | 2% |
| MANKIND PHARMA | -1.3% | -8.8% | -14.7% |
| ZYDUS LIFESCIENCES | -1.7% | -7.4% | -2.9% |
| LUPIN | -1.2% | 4.4% | 0.6% |
FDC Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | -27.05 % |
| Y-o-Y | -7.94 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Sep2025 | ₹473 Cr | -27.05 | |
| Jun2025 | ₹648 Cr | 31.82 | |
| Mar2025 | ₹492 Cr | 5.98 | |
| Dec2024 | ₹464 Cr | -9.68 | |
| Sep2024 | ₹514 Cr | -19.49 | |
| Jun2024 | ₹638 Cr | 38.14 | |
| Mar2024 | ₹462 Cr | 0.84 | |
| Dec2023 | ₹458 Cr | - | |
FDC Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | -75.90 % |
| Y-o-Y | -51.80 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Sep2025 | ₹34 Cr | -75.90 | |
| Jun2025 | ₹140 Cr | 159.98 | |
| Mar2025 | ₹54 Cr | 15.71 | |
| Dec2024 | ₹47 Cr | -33.51 | |
| Sep2024 | ₹70 Cr | -52.15 | |
| Jun2024 | ₹147 Cr | 160.31 | |
| Mar2024 | ₹56 Cr | -32.78 | |
| Dec2023 | ₹84 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -66.96 % |
| Y-o-Y | -47.62 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Sep2025 | 7.15% | -66.96 | |
| Jun2025 | 21.64% | 97.27 | |
| Mar2025 | 10.97% | 9.15 | |
| Dec2024 | 10.05% | -26.37 | |
| Sep2024 | 13.65% | -40.57 | |
| Jun2024 | 22.97% | 88.43 | |
| Mar2024 | 12.19% | -33.35 | |
| Dec2023 | 18.29% | - | |
FDC Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -76.62 % |
| Y-o-Y | -60.62 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Sep2025 | ₹28 Cr | -76.62 | |
| Jun2025 | ₹121 Cr | 213.81 | |
| Mar2025 | ₹39 Cr | 4.40 | |
| Dec2024 | ₹37 Cr | -48.58 | |
| Sep2024 | ₹72 Cr | -39.48 | |
| Jun2024 | ₹119 Cr | 157.20 | |
| Mar2024 | ₹46 Cr | -41.54 | |
| Dec2023 | ₹79 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -67.95 % |
| Y-o-Y | -57.20 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Sep2025 | 6 % | -67.95 | |
| Jun2025 | 18.72 % | 138.17 | |
| Mar2025 | 7.86 % | -1.50 | |
| Dec2024 | 7.98 % | -43.08 | |
| Sep2024 | 14.02 % | -24.83 | |
| Jun2024 | 18.65 % | 86.13 | |
| Mar2024 | 10.02 % | -42.01 | |
| Dec2023 | 17.28 % | - | |
FDC Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | -76.64 % |
| Y-o-Y | -60.63 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Sep2025 | ₹1.74 | -76.64 | |
| Jun2025 | ₹7.45 | 213.03 | |
| Mar2025 | ₹2.38 | 4.39 | |
| Dec2024 | ₹2.28 | -48.42 | |
| Sep2024 | ₹4.42 | -39.53 | |
| Jun2024 | ₹7.31 | 157.39 | |
| Mar2024 | ₹2.84 | -41.68 | |
| Dec2023 | ₹4.87 | - | |
You may also like the below Video Courses